Symptom management in amyotrophic lateral sclerosis: We can do better.

about

Symptom management in amyotrophic lateral sclerosis: We can do better.

Item

http://www.wikidata.org/entity/Q47102766

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Symptom management in amyotrophic lateral sclerosis: We can do better.

@en

Symptom management in amyotrophic lateral sclerosis: We can do better.

@nl

type

Item

label

Symptom management in amyotrophic lateral sclerosis: We can do better.

@en

Symptom management in amyotrophic lateral sclerosis: We can do better.

@nl

prefLabel

Symptom management in amyotrophic lateral sclerosis: We can do better.

@en

Symptom management in amyotrophic lateral sclerosis: We can do better.

@nl

P1476

Symptom management in amyotrophic lateral sclerosis: We can do better.

@en

P2093

Zachary Simmons

http://www.w3.org/2001/XMLSchema#string

P2860

Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect

Supportive and symptomatic management of amyotrophic lateral sclerosis.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Patient-reported problematic symptoms in an ALS treatment trial.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Rehabilitation of motor neuron disease.

Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.

Improving symptom management for people with amyotrophic lateral sclerosis.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/MUS.25740

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen A Goutman

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28681465

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5749258

http://www.w3.org/2001/XMLSchema#string